Will Moderna's Coronavirus Vaccine Really Change the Game?
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more.
Moderna's (NASDAQ: MRNA) CEO Stephane Bancel calls his company's vaccine candidate a "game changer." But he's not talking about the mRNA technology that powers the vaccine. Instead, he's referring to one particular measure of performance in the vaccine's late-stage clinical trial: the ability of the vaccine to prevent severe disease.
Could this element make Moderna's vaccine the market leader? Well, it depends on final results from ongoing analyses of Moderna's late-stage trial. And it also depends on results from other vaccine makers. Let's have a closer look at what we know right now.
Source Fool.com
